EGFR in 2026: What’s New and What’s Next

Nick Baker, Web Experience and Content Manager
EGFR lung cancer in 2026

LUNGevity offers a variety of virtual support groups called ‘meetups’ where survivors and caregivers impacted by lung cancer connect with others who understand the patient experience.

Once a month, we invite an expert to share information on a topic related to life with lung cancer, engage with attendees, and answer questions in real time. Visit the LUNGevity Calendar to see upcoming events like this one.

In September, we were joined by Dr. Benjamin Levy, MD, thoracic medical oncologist and clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy walked us through the latest updates in EGFR-mutated NSCLC treatment, clinical trials, next-generation drugs, and effective side effect management.